Skip to main content

Defining Breast Cancer Prevention

  • Chapter
Approaches to Breast Cancer Prevention

Part of the book series: Developments in Oncology ((DION,volume 62))

  • 49 Accesses

Abstract

Practical methods of avoidance (proscriptive measures) on intervention (prescriptive methods) may reduce a woman’s risk of developing breast cancer. This book evaluates the measures, discusses current trials of intervention methods and the likely direction of future research in this field. While it distinguishes strategies for risk avoidance, chemosuppression, chemoprevention and secondary prevention, the present state of knowledge does not permit a scientifically-based model for breast cancer prevention.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Haybittle, J.L. (1983). What is cure in cancer? In Stoll, B.A. (ed.), Cancer Treatment: End-point Evaluation, John Wiley, Chichester, 3–21.

    Google Scholar 

  2. Ketcham, A.S., Moffat, F.L. (1990). Vexed surgeons, perplexed patients and breast cancers which may not be cancer. Cancer, 65, 387–393.

    Article  PubMed  CAS  Google Scholar 

  3. Roe, F.J.C. (1983). Chemical carcinogenesis; animals and man. In Symingon, T., Carter, R.L. (eds.), Scientific Foundations of Oncology, Heinemann Medical, London, 265–272.

    Google Scholar 

  4. Farber, E. (1988). Cancer development and its natural history; a cancer prevention perspective. Cancer, 62, 1676–1679.

    Article  PubMed  CAS  Google Scholar 

  5. Nowell, P.C. (1988). Molecular events in tumor development. N. Engl. J. Med., 319, 575–577.

    Article  PubMed  CAS  Google Scholar 

  6. Schottenfeld, D. (1986). Genetic and environmental factors in human carcinogenesis. J. Chron. Dis., 39, 1021–1030.

    Article  PubMed  CAS  Google Scholar 

  7. Sachs, L. (1978). Control of normal cell differentiation and the phenotypic reversion of malignancy in myeloid leukemia. Nature, 274, 535–536.

    Article  PubMed  CAS  Google Scholar 

  8. Nowell, P.C. (1986). Mechanisms of tumor progression. Cancer Res., 46, 2203–2207.

    PubMed  CAS  Google Scholar 

  9. Sporn, M.B., Roberts, A.B. (1983). Role of retinoids in differentiation and carcinogenesis. Cancer Res., 43, 3034–3040.

    PubMed  CAS  Google Scholar 

  10. Tokumaga, M., Norman, J.E., Asano, M. et al. (1979). Malignant breast tumours among atomic bomb survivors. J. Natl. Cancer Inst., 62, 1347–1359.

    Google Scholar 

  11. Pons, J.Y., Huber, C.J. (1978). Fibrocystic disease of the breast. In Marchant, D.J., Nyirjesy, I. (eds.), Breast Disease, Grune and Stratton, New York, 20–30.

    Google Scholar 

  12. Seidman, H., Stellman, S.D., Mushinski, M.H. (1982). A different perspective on breast cancer risk factors; some implications of the non-attributable risk. C.A., 32, 301–313.

    CAS  Google Scholar 

  13. Ohuchi, N., Thor, A., Page, D.L. et al. (1986). Expression of 21K ras protein in a spectrum of benign and malignant human mammary tissues. Cancer Res., 46, 2511–2519.

    PubMed  CAS  Google Scholar 

  14. Haggie, J.A., Sellwood, R.A., Howell, A. et al. (1987). Fibroblasts from relatives of patients with hereditary breast cancer show fetal-like behaviour in vitro. Lancet, i, 1455–1457.

    Article  Google Scholar 

  15. Garcia, M., Salazar, R.G., Pages, A. et al. (1986). Distribution of 52K oestrogen-regulated protein in benign breast disease and other tissue by immunohisto-chemistry. Cancer Res., 46, 3734–3738.

    PubMed  CAS  Google Scholar 

  16. Cuzick, J. (1987). Women at high risk of breast cancer. Rev. Endoc. Rel. Cancer, 25, 5–10.

    Google Scholar 

  17. Dupont, W.D., Page, D.L. (1989). Relationship of breast cancer to previous breast disease. In Stoll, B.A. (ed.), Women at High Risk to Breast Cancer, Kluwer Dordrecht, 47–56.

    Chapter  Google Scholar 

  18. Vessey, M. (1981). A review of the risk factors in breast cancer. Rev. Endoc. Rel. Cancer, 10 (suppl.) 41–48.

    Google Scholar 

  19. Wynder, E.L., MacComack, F.A., Stellman, S.D. (1978). Epidemiology of breast cancer in 785 Caucasian U.S. women. Cancer, 41, 2341–2354

    Article  PubMed  CAS  Google Scholar 

  20. Bulbrook, R.D., Hayward, J. (1981). Women at high risk of breast cancer. Rev. Endoc. Rel. Cancer, 25, 5–10.

    Google Scholar 

  21. Strax, P. (1981), Women at high risk of breast cancer. Rev. Endoc. Rel. Cancer, 25, 5–10.

    Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1991 Springer Science+Business Media Dordrecht

About this chapter

Cite this chapter

Stoll, B.A. (1991). Defining Breast Cancer Prevention. In: Stoll, B.A. (eds) Approaches to Breast Cancer Prevention. Developments in Oncology, vol 62. Springer, Dordrecht. https://doi.org/10.1007/978-94-011-3742-3_1

Download citation

  • DOI: https://doi.org/10.1007/978-94-011-3742-3_1

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-94-010-5664-9

  • Online ISBN: 978-94-011-3742-3

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics